Cipla LtdNSE: CIPLA

Press Release Aug 25 2021

· Issued by Cipla Ltd

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Cipla and Kemwell Biopharma have announced a joint venture agreement for developing, manufacturing, and commercializing biosimilars. The joint venture aims to leverage the strengths of both companies to enhance product development and market entry in the respiratory biosimilars space. This partnership is expected to accelerate Cipla's global leadership in respiratory therapy and address unmet patient needs worldwide.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Cipla Limited has informed the Exchange regarding a press release dated August 25, 2021, titled "Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars".

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases